Autoimmunity BioSolutions

Seed
abstherapeutics.com Biotech & Healthcare Houston, United States
Total Funding $2M
Latest Round Undisclosed Seed
Last Announced May 6, 2026
Investors Undisclosed
Decision Makers 4 Verified

About Autoimmunity BioSolutions

Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Houston, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website abstherapeutics.com
Domain Registered Date Aug 21, 2017

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

    startupintros.com

  2. Capital Raise

    Raised $2,000,000 · Seed

    startupintros.com

  3. Milestone

    Website domain registered

    abstherapeutics.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Autoimmunity BioSolutions.

Funding History

2 Rounds
Seed · May 6, 2026
Seed · Nov 28, 2024

Founders & Leadership

1

Gaddiel Galarza-Munoz

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts